Table 1:

Description of patient episodes, follow up time and overdose deaths during study period 2015–2016

Number of Patients	48,274
Patients with medication treatment episodes only	23,992 (49.70%)
Patients with non-medication treatment episodes only	13,497 (27.96%)
Patients with both medication and non-medication treatment episodes	10,785 (22.34%)
Number of Follow-Up Episodes	185,568
During non-medication treatment	44,176 (23.81%)
During medication treatment*	55,016 (29.65%)
After non-medication treatment	37,863 (20.40%)
After medication treatment	48,513 (26.14%)
Average Length of Follow up Episodes	123 days
During non-medication treatment	22 days
During medication treatment	248 days
After non-medication treatment	118 days
After medication treatment	79 days
Average In-Treatment Episodes per Patient	2
Substances Involved in Opioid Overdose Deaths During Follow Up	371
Prescription opioids	130 (35.04%)
Methadone	114 (30.73%)
Heroin	241 (64.96%)
Fentanyl	213 (57.41%)

^*Of the 55,016 medication treatment episodes, 93.31% involved methadone, and 6.69% involved buprenorphine